LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 40.14 | 84.90 | 372 | 3682 | 0.1010 | 0.3121 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 40.14 | 84.90 | 4298 | 3682 | 1.1673 | 1.0577 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.84 | 84.90 | 246 | 4003 | 0.0615 | 0.2109 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.84 | 84.90 | 3432 | 4003 | 0.8573 | 0.9454 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.84 | 84.90 | 436 | 4003 | 0.1089 | 0.3422 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.84 | 84.90 | 4596 | 4003 | 1.1481 | 1.0503 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.55 | 84.90 | 289 | 4287 | 0.0674 | 0.2417 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.55 | 84.90 | 3669 | 4287 | 0.8557 | 0.9457 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.55 | 84.90 | 511 | 4287 | 0.1192 | 0.3733 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.55 | 84.90 | 4908 | 4287 | 1.1446 | 1.0483 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.25 | 84.90 | 328 | 4539 | 0.0722 | 0.2655 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.25 | 84.90 | 3972 | 4539 | 0.8749 | 0.9540 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.25 | 84.90 | 528 | 4539 | 0.1163 | 0.3749 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.25 | 84.90 | 5290 | 4539 | 1.1652 | 1.0540 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.95 | 84.90 | 356 | 4952 | 0.0719 | 0.2768 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.95 | 84.90 | 4227 | 4952 | 0.8535 | 0.9467 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.95 | 84.90 | 648 | 4952 | 0.1308 | 0.4141 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.95 | 84.90 | 5816 | 4952 | 1.1743 | 1.0555 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.65 | 84.90 | 421 | 5328 | 0.0790 | 0.3075 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.65 | 84.90 | 4484 | 5328 | 0.8415 | 0.9430 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.65 | 84.90 | 650 | 5328 | 0.1220 | 0.4061 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.65 | 84.90 | 6253 | 5328 | 1.1734 | 1.0543 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.36 | 84.90 | 405 | 5651 | 0.0717 | 0.2943 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.36 | 84.90 | 4809 | 5651 | 0.8510 | 0.9474 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.36 | 84.90 | 802 | 5651 | 0.1419 | 0.4489 | MN20160318_Q02 | I21 |